Saturday, February 28, 2015
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

$1,000-a-pill Sovaldi jolts US health care system

By
From page A10 | June 18, 2014 |

WASHINGTON — Your money or your life?

Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.

Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are gagging on the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.

Yet if Sovaldi didn’t exist, insurers would still be paying in the mid-to-high five figures to treat the most common kind of hepatitis C, a new pricing survey indicates. Some of the older alternatives involve more side effects, and are less likely to provide cures.

So what’s a fair price?

The cost of this breakthrough drug is highlighting cracks in the U.S. health care system at a time of heightened budget concerns. The Obama administration has a huge political stake in controlling treatment costs, but its critics may cry rationing.

“People are going to want to try to dodge this hot potato,” says economist Douglas Holtz-Eakin.

For insurers, there’s a frustrating twist: For each middle-aged person they pay to cure with Sovaldi, any financial benefits from preventing liver failure are likely to accrue to Medicare, not to them.

More than 3 million Americans carry the hepatitis C virus, and many don’t realize it. It’s a public health concern since the disease can be transmitted by contact with infected blood, and sometimes through sexual activity. Health officials advise all baby boomers to get tested.

The illness is complex, with distinct virus types requiring different treatments. While it progresses gradually, it can ultimately destroy the liver, and transplants average $577,000.

An estimated 15,000 people died from hepatitis C in the U.S. in 2007, when it surpassed AIDS as a cause of death.

“If it’s going to get me the medicine, I’ll put my hand out there with a tin cup,” said Stuart Rose, a hepatitis C patient in New York City. His insurance would pay only $4,000 a year for medications, but Rose was able to get assistance from charitable foundations. He recently started taking Sovaldi.

Until the drug’s approval late last year, standard treatment for the most common type of the disease required daily pills and extended use of interferon, an injection that can produce debilitating flu-like symptoms. “Brain fog,” said Rose.

Taken once a day for 12 weeks, Sovaldi greatly reduces the length of interferon treatment, making things more tolerable for patients. Now, many more people might want to try the cure.

A similar drug, Olysio, also approved last year, is priced a bit lower.

The nation’s largest care provider for chronic hepatitis C, the federal Veterans Administration, sees promise. With 175,000 patients, the VA has started more than 1,850 of them on Sovaldi.

“After 20 years in infectious diseases, I never thought we would be in a position to cure this disease,” said Dr. David Ross, head of the VA’s program.

By law, the VA gets drug discounts of over 40 percent. Will the agency break even by avoiding the disease’s worst complications?

Not necessarily, said Ross. “If it leads to cost benefits in the long run, that’s gravy.”

Private insurers will probably introduce Sovaldi gradually. “Not everybody is going to get this all at once,” said former Medicare administrator Mark McClellan.

Drug maker Gilead Sciences, Inc., reported Sovaldi sales of $2.3 billion worldwide in just the first three months of this year. Gilead will not disclose its pricing methods, but vice president Gregg Alton said the drug’s high cure rate makes it “a real huge value.”

In many countries, the government sets drug prices. In the US, insurers negotiate with drug companies. Medicare is forbidden from bargaining, a situation that critics say saddles U.S. patients with high costs while subsidizing the rest of the world.

The Associated Press asked DRX, a technology company that researches drug prices for major insurers and government programs, to look at Sovaldi. The findings:

— There aren’t many deep discounts:

The midpoint — or median— discount that private payers are securing is about 14 percent off the average wholesale price of $1,200 a pill, bringing it down to $1,037. The biggest discount DRX found was nearly 36 percent, approaching the VA rate, and bringing the cost to $773. DRX surveyed more than 300 payers.

— How do other drugs compare?

DRX compared the total drug cost of treating the most common type of hepatitis C with Sovaldi and three alternatives. The regimen included pills, interferon and an antiviral called ribavirin.

Treatment with Sovaldi had the highest cost, a median of $97,376. The lowest was $48,084 for Victrelis, a somewhat older drug with a lower cure rate.

Two others were about $8,000 less than Sovaldi. The total median cost with Incivek was $89,178. With Olyisio, it was $89,319.

“While Sovaldi still is the most expensive, all of these are five-figure regimens,” said Jim Yocum, DRX executive vice president. “Sovaldi is an advance … and it doesn’t seem to be priced completely out of whack.”

But Dr. Sharon Levine, a top official working on drug policy with insurer Kaiser Permanente, disagrees.

“There was never any question that we would cover and prescribe this drug,” said Levine. But she firmly believes the price is out of line. Countries where the government sets drug prices are paying much less, she noted.

U.S. insurers aren’t interested in price controls, said Levine, but “eventually the American public is going to start getting very uncomfortable” with high prices. Drug costs have moderated in recent years, but new medications in the pipeline for cancer and other diseases are expected to push spending up.

The California Technology Assessment Forum, a private group that reviews medical treatments, recently voted Sovaldi a “low value,” because it would be cost-prohibitive to treat the high number of potentially eligible patients. But after their own assessment, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases issued clinical guidelines recommending that doctors use Sovaldi as a primary treatment.

Meanwhile, Gilead has a new hepatitis C pill close to approval that will not require interferon use.

There’s no word on how it will be priced.

 

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

US / World

Man shoots wife, himself at Northern Calif. retirement home

By The Associated Press | From Page: A3

 
 
Thieves crash car through electronics store in San Francisco

By The Associated Press | From Page: A4

 
Some California farmers to go without federal water

By The Associated Press | From Page: A4, 2 Comments | Gallery

US, Liberia start 1st formal test of ZMapp Ebola virus drug

By The Associated Press | From Page: A5

 
US appeals court: Marathon bombing trial can stay in Boston

By The Associated Press | From Page: A5

 
Congress OKs 1-week bill to keep Homeland Security open

By The Associated Press | From Page: A5, 2 Comments | Gallery

US rescinds rule requiring judges to move to Guantanamo

By The Associated Press | From Page: A5

 
Woman knocked out by eggs

By The Associated Press | From Page: A9

Mexico official: Police capture top capo ‘La Tuta’ Gomez

By The Associated Press | From Page: A10 | Gallery

 
Well-educated ‘Jihadi John’ no surprise to experts

By The Associated Press | From Page: A10

Unmasking of ‘Jihadi John’ as a London lad shocks Britain

By The Associated Press | From Page: A10

 
.

Opinion

A remedy for veterans’ care

By Bill Frist And Jim Marshall | From Page: A8

 
Editorial Cartoon: Feb. 28, 2015

By Daily Republic Syndicated Content | From Page: A8

How GOP can resolve immigration mess

By Ramesh Ponnuru | From Page: A8, 10 Comments

 
Unlikely winners of Greece’s surrender on euro

By Mark Gilbert | From Page: A8

.

Living

Community Calendar: Feb. 28, 2015

By Susan Hiland | From Page: A2

 
Today in History: Feb. 28, 2015

By The Associated Press | From Page: A2

Horoscopes: Feb. 28, 2015

By Holiday Mathis | From Page: A7

 
Poem about heaven helps dog owners when beloved pet dies

By Kathy Mitchell and Marcy Sugar | From Page: A7, 1 Comment

Coca-Cola bottle as art? Atlanta’s High Museum takes a look

By The Associated Press | From Page: B8

 
.

Entertainment

 
TVGrid

By Daily Republic Syndicated Content | From Page: B9

.

Sports

 
Vaca advances three wrestlers into semis at Masters

By Daily Republic staff | From Page: B1

 
Spurs snap 4-game skid, beat short-handed Kings 107-96

By The Associated Press | From Page: B1

Thompson scores 25 points, Warriors rout Raptors 113-89

By The Associated Press | From Page: B1

 
Casey McGehee’s move to Giants a homecoming of sorts

By The Associated Press | From Page: B1

Browns agree to terms with quarterback Josh McCown

By The Associated Press | From Page: B2

 
Kyle Busch released from hospital following foot surgery

By The Associated Press | From Page: B2

 
Bulls expect Derrick Rose back this season from knee surgery

By The Associated Press | From Page: B2

Testimony: Several Hernandez texts are missing from phone

By The Associated Press | From Page: B2

 
Approaching ‘last call’ for NHL GMs to tweak rosters

By The Associated Press | From Page: B2

PGA Tour to move Match Play to Texas

By The Associated Press | From Page: B2

 
Notre Dame president credited for transforming school dies

By The Associated Press | From Page: B2

MLS Commissioner Garber: Hopeful season will start on time

By The Associated Press | From Page: B2

 
Travis Kvapil’s NASCAR car stolen from hotel before race

By The Associated Press | From Page: B2

McIlroy to miss cut at Honda Classic; Reed leads

By The Associated Press | From Page: B2

 
NHL fines Sharks’ Couture $5,000 for tripping from behind

By The Associated Press | From Page: B2

 
This date in sports history for Saturday, Feb. 28, 2015

By The Associated Press | From Page: B4

.

Business

Gas prices soar in California as supply shrinks

By The Associated Press | From Page: A1, 1 Comment | Gallery

 
Tribes from around US gather to discuss legal marijuana

By The Associated Press | From Page: B5

Uber says database containing driver info was breached

By The Associated Press | From Page: B5

 
Signed contracts to buy US homes rise to 18-month high

By The Associated Press | From Page: B5

Fiat Chrysler recalls 467K SUVs for possible stalling

By The Associated Press | From Page: B5

 
Southwest nearly done inspecting planes that were grounded

By The Associated Press | From Page: B5

 
5 reasons US economy is stronger than Q4 GDP suggests

By The Associated Press | From Page: B5 | Gallery

.

Obituaries

Gabriel T. Traub

By Nancy Green | From Page: A4, 1 Comment

 
Maria Kraszewski

By Nancy Green | From Page: A4

.

Comics

B.C.

By Daily Republic Syndicated Content | From Page: A6

 
Peanuts

By Daily Republic Syndicated Content | From Page: A6

Rose is Rose

By Daily Republic Syndicated Content | From Page: A6

 
Zits

By Daily Republic Syndicated Content | From Page: A6

Pickles

By Daily Republic Syndicated Content | From Page: A6

 
Baldo

By Daily Republic Syndicated Content | From Page: A6

Sally Forth

By Daily Republic Syndicated Content | From Page: A6

 
Garfield

By Daily Republic Syndicated Content | From Page: A6

Blondie

By Daily Republic Syndicated Content | From Page: A6

 
For Better or Worse

By Daily Republic Syndicated Content | From Page: A6

Get Fuzzy

By Daily Republic Syndicated Content | From Page: A6

 
Beetle Bailey

By Daily Republic Syndicated Content | From Page: A6

Dilbert

By Daily Republic Syndicated Content | From Page: A6

 
Wizard of Id

By Daily Republic Syndicated Content | From Page: A6

Baby Blues

By Daily Republic Syndicated Content | From Page: A6

 
Frank and Ernest

By Daily Republic Syndicated Content | From Page: A6

Sudoku

By Daily Republic Syndicated Content | From Page: A7

 
Bridge

By Daily Republic Syndicated Content | From Page: A7

Crossword

By Daily Republic Syndicated Content | From Page: A7

 
Word Sleuth

By Daily Republic Syndicated Content | From Page: A7

Cryptoquote

By Daily Republic Syndicated Content | From Page: A7

 
.

Home Seller 2/28/2015

Right at Home: Decor made of bicycle parts

By The Associated Press | From Page: HSR2Comments are off for this post | Gallery

Real estate transactions for Feb. 28, 2015

By Daily Republic | From Page: HSR3

Average US rate on 30-year mortgage rises to 3.80 percent

By The Associated Press | From Page: HSR3